The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening-Reference-Cited by-同舟云学术

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening

Published:2019-11-25 Issue:3 Volume:63 Page:588-596
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Jacobsen Laura M.^ORCID,Bocchino Laura,Evans-Molina Carmella,DiMeglio Linda,Goland Robin,Wilson Darrell M.,Atkinson Mark A.,Aye Tandy,Russell William E.,Wentworth John M.,Boulware David,Geyer Susan,Sosenko Jay M.

Funder

TrialNet is supported by NIH and JDRF

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-019-05047-w.pdf

Reference36 articles.

1. Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 48(3):460–468. https://doi.org/10.2337/diabetes.48.3.460

2. Steck AK, Vehik K, Bonifacio E et al (2015) Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38(5):808–813. https://doi.org/10.2337/dc14-2426

3. Vehik K, Lynch KF, Schatz DA et al (2016) Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY Study. Diabetes Care 39(9):1535–1542. https://doi.org/10.2337/dc16-0181

4. ClinicalTrials.gov (2017) Type 1 Diabetes Prediction and Prevention (DIPP) Study (DIPP). Available from https://clinicaltrials.gov/ct2/show/NCT03269084. Accessed 2 February 2018

5. Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473–2479. https://doi.org/10.1001/jama.2013.6285

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 1 diabetes: immune pathology and novel therapeutic approaches;Diabetology International;2024-09-11

2. Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts français;Médecine des Maladies Métaboliques;2024-09

3. Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age;Frontiers in Endocrinology;2024-08-12

4. Polymer scaffolds delineate healthy from diseased states at sites distal from the pancreas in two models of type 1 diabetes;Biotechnology and Bioengineering;2024-07-31

5. Recommendations for Screening and Monitoring the Stages of Type 1 Diabetes in the Immune Therapy Era;International Journal of General Medicine;2024-07